Health and Fitness

Stem Cell Transplants May Halt Progression of Multiple Sclerosis

NIH-funded study yields encouraging early results

Bethesda, Maryland--(ENEWSPF)--December 30, 2014.  Three-year outcomes from an ongoing clinical trial suggest that high-dose immunosuppressive therapy followed by transplantation of a person's own blood-forming stem cells may induce sustained remission in some people with relapsing-remitting multiple sclerosis (RRMS). RRMS is the most common form of MS, a progressive autoimmune disease in which the immune system attacks the brain and spinal cord. The trial is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and conducted by . . .

STEEL MAGNOLIAS is coming to The Drama Group

First Trustee Forum

First Mayoral Forum

Please follow & like us :)

ARCHIVES